DIF originally invested in the UKSH PPP project in 2014, alongside current co-shareholders Invesis and VAMED Health Project GmbH (“VAMED”).
DIF Capital Partners is a leading global independent fund manager, with more than €14.0 billion in assets under management across eleven closed-end infrastructure funds and several co-investment vehicles. DIF Capital Partners invests in greenfield and operational infrastructure assets located primarily in Europe, the Americas, and Australasia. DIF Capital Partners has a team of over 190 professionals, based in eleven offices located in Amsterdam (Schiphol), Frankfurt, Helsinki, London, Luxembourg, Madrid, New York, Paris, Santiago, Sydney, and Toronto. For more information please visit www.dif.eu.
The Herbert Smith Freehills team was led by Dr. Christoph Nawroth (Corporate/M&A, Düsseldorf), and included Tom Marshall (Corporate/M&A, London), Dr. Marcel Nuys (Competition, Düsseldorf), Kai Liebrich (Finance), Dr. Steffen Hörner (Tax, both Frankfurt); Counsel Dr. Sebastian Schürer (Corporate/M&A, Düsseldorf), Dr. Hannes Jacobi (Finance, Frankfurt); Associates: Kristina Endemann, Tobias Beuker, Stefanie Strahl (all Corporate/M&A, all Düsseldorf), Tatiana Günster (Tax, Frankfurt).